Credit Suisse Upgrades St. Jude Medical To Outperform

Analysts at Credit Suisse upgraded

from Neutral to Outperform. The price target for St. Jude Medical has been raised from $74.00 to $84.00. St. Jude Medical shares have gained 17.66 percent over the past 52 weeks, while the S&P 500 index has surged 12.21 percent in the same period. St. Jude Medical shares rose 6.41 percent to close at $73.55 yesterday.